+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

  • PDF Icon

    Report

  • 52 Pages
  • September 2021
  • Region: Global
  • GlobalData
  • ID: 5447129
This report is the companion to Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion (July 2020). IT covers contract manufacturing agreements for COVID-19 vaccines and drugs worldwide, across a range of different services and manufacturing scales. It covers clinical and commercial contracts. As COVID-19 pharmaceuticals are being ordered in billions of doses by numerous governments, the number of contract service agreements secured serves as an indicator of a CMO's performance. This report is critical for establishing an understanding of the overall CMO industry as it responds to the challenges and opportunities of the pandemic.

Scope


  • This 52-page report gives an important expert quantitative analysis of the contract manufacturing industry's response to the COVID-19 pandemic. Findings are based on the industry’s most comprehensive databases of the CMO industry (the publisher's Databases of Contract Service Providers, Drugs, and Deals).

- This analysis is primarily driven by the Deals Database, which is continuously updated and reveals manufacturing relationships for Pharma products and the types of services offered. The 23 figures and 6 tables throughout the report illustrate major points and trends. This report is required reading for:


  • CMO executives who must have deep understanding of the COVID-19 vaccine and drug landscape -- both pipeline and marketed -- to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy


  • Overview of contract manufacturing agreements worldwide for COVID-19 pharmaceuticals and the levels of outsourcing associated with different services and drug type
  • Detailed view of CDMO performance by contract manufacturing agreement and an assessment of their manufacturing scale
  • Manufacturing agreements are assessed by different molecule types, service type, dose form, facility geography, sponsor company types, and CDMO types.

Table of Contents

1. Executive Summary

2 Players

3 Trends

4 Industry Analysis

5 Value Chain: Contract Manufacturing Service Agreements

6 Appendix

7 Companies

8 About the Authors

List of Tables
Table 1: Top Trends in COVID-19 Contract Manufacturing
Table 2: Promising Pipeline Therapies
Table 3: Promising Pipeline Vaccines
Table 4: Marketed Therapies and Vaccines
Table 5: Further Reading
Table 6: CDMOs with COVID-19 Contract Manufacturing Agreements

List of Figures
Figure 1: Leaders and Disruptors: Top Players in Outsourcing COVID-19 Vaccine/Therapeutic Manufacturing
Figure 2: Pipeline Therapies in Development for COVID-19
Figure 3: Pipeline Vaccines in Development for COVID-19
Figure 4: Clinical Trials of COVID-19 Therapies and Vaccines
Figure 5: The Contract Manufacturing Value Chain
Figure 6: COVID-19 Vaccine and Therapy Contract Manufacturing Agreements
Figure 7: Contract Manufacturing Agreements for COVID-19 Vaccines and Therapies - Manufacturing Facility Geography
Figure 8: Contract Manufacturing Agreements for COVID-19 Vaccines and Therapies - Manufacturing Facility Country
Figure 9: Contract Manufacturing Agreements for COVID-19 Vaccines - Manufacturing Facility Geography
Figure 10: Contract Manufacturing Agreements for COVID-19 Therapies - Manufacturing Facility Geography
Figure 11: COVID-19 Contract Manufacturing Agreements by Molecule Type
Figure 12: Contract Manufacturing Agreements by Service Type
Figure 13: Contract Manufacturing Agreements by Dosage Form
Figure 14: Outsourcing by API/Dose/Packaging
Figure 15: Count of Services Per Contract
Figure 16: Contract Manufacturing Agreements - Scale of Services
Figure 17: Top CDMOs by COVID-19 Contract Service Agreements
Figure 18: CDMOs with COVID-19 Contract Manufacturing Agreements - by Market Cap
Figure 19: Market Cap Bands of CDMOs (Therapies vs. Vaccines)
Figure 20: Contract Manufacturing Agreements by Top Products/Sponsors
Figure 21: Vaccine Contract Volume, Gamaleya and AstraZeneca
Figure 22: Vaccine API Contract Manufacturing Facilities, Worldwide
Figure 23: Vaccine API Contract Manufacturing Facilities, US

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ABF Pharmaceutical Services GmbH
  • Abzena Ltd
  • Adienne Pharma & Biotech SA
  • Advanced BioScience Laboratories Inc
  • Advent Srl
  • AGC Biologics Inc
  • Ajinomoto Bio-Pharma Services
  • Akron Biotechnology LLC
  • Aldevron LLC
  • Allergopharma GmbH & Co KG
  • Almac Group Ltd
  • Amgen Inc
  • Apeptico Forschung und Entwicklung GmbH
  • Aragen Bioscience Inc
  • Aspen Pharmacare Holdings Ltd
  • AstraZeneca UK Ltd
  • Attwill Medical Solutions
  • Avid Bioservices Inc
  • Avra Laboratories Pvt Ltd
  • Bachem Holding AG
  • Bajaj Healthcare Ltd
  • Batavia Biosciences BV
  • Bausch Health Companies Inc
  • Baxter Biopharma Solutions
  • Bayer AG
  • BDR Pharmaceuticals Internationals Pvt Ltd
  • Beijing Institute of Biological Products
  • Beijing Minhai Biotechnology Co Ltd
  • Bharat Biotech Ltd
  • Binnopharm JSC
  • Biocad
  • BioCell Corp Ltd
  • BioCentriq
  • Biocon Ltd
  • BioConvergence LLC
  • Biofabri SL
  • Biogen Inc
  • Biological E Ltd
  • BioNTech SE
  • Biotechpharma UAB
  • Bryllan LLC
  • Cadila Healthcare Ltd
  • Cambrex Corp
  • Cascade Chemistry
  • Catalent Inc
  • Celltrion Inc
  • Celonic AG
  • Cenexi SAS
  • Centaur Biopharmaceutical Services Inc
  • Chime Biologics Ltd
  • CinnaGen Ilac San ve Tic AS
  • Cipla Ltd
  • Clover Biopharmaceuticals
  • CMIC Holdings Co Ltd
  • Cobra Biologics Ltd
  • CSL Behring Australia Pty Ltd
  • Curia Inc
  • Daiichi Sankyo Biotech Co Ltd
  • Dalton Pharma Services
  • Delpharm SAS
  • Dr. Reddy's Laboratories Ltd
  • Drugmex SAPI de CV
  • Dyadic International Inc
  • Eli Lilly and Co
  • Emergent BioSolutions Inc
  • Esteve Huayi Pharmaceutical Co Ltd
  • EUSA Pharma
  • Exelead Inc
  • Exothera SA
  • Fareva SA
  • Flamma SpA
  • Fujifilm Corp
  • GALENpharma GmbH
  • Gamaleya Federal Research Center of Epidemiology and Microbiology
  • GC Pharma
  • Genentech USA Inc
  • Generium
  • Genscript Biotech Corp
  • Gilead Sciences Inc
  • Gland Pharma Ltd
  • GlaxoSmithKline Inc
  • Goodwin Biotechnology Inc
  • Grand River Aseptic Manufacturing Inc
  • Haffkine Bio-Pharmaceutical Corp Ltd
  • Hainan Visum Pharmaceutical Co Ltd
  • Halix BV
  • Hankook Korus Pharm Co Ltd
  • Hester Biosciences Ltd
  • Hetero Drugs Ltd
  • Hikma Pharmaceuticals Plc
  • Hoffmann-La Roche Ltd
  • Hualan Biological Engineering Inc
  • Humanigen
  • iBio Inc
  • IDT Biologika GmbH
  • Indian Immunologicals Ltd
  • Institute of Medical Biology Chinese Academy of Medical Sciences
  • Institute of Virology Vaccines and Sera Torlak
  • Insud Pharma
  • IriSys LLC
  • ISU ABXIS Co Ltd
  • Janssen Biotech Inc
  • JCR Pharmaceuticals Co Ltd
  • Jubilant HollisterStier LLC
  • Jubilant Pharmova Ltd
  • Julphar Saudi Arabia LLC
  • Kaneka Corp
  • Kaneka Eurogentec SA
  • Kern Pharma SL
  • KM Biologics Co Ltd
  • Laboratorio Reig Jofre SA
  • Laboratorios de Biologicos y Reactivos de Mexico SA de CV
  • Laboratorios Farmaceuticos Rovi SA
  • Laboratorios Richmond SACIF
  • LakePharma Inc
  • LFB Biomanufacturing
  • List Biological Laboratories Inc
  • Lonza Group Ltd
  • Mabxience Holding SL
  • Mankind Pharma Ltd
  • Medicago
  • Merck
  • Merck & Co Inc
  • Mibe GmbH Arzneimittel
  • MilliporeSigma
  • Mithra Pharmaceuticals SA
  • Moderna Inc
  • Morepen Laboratories Ltd
  • National Resilience Inc
  • National Resilience Inc (including subsidiaries Ology Bioservices Inc, Therapure Biopharma Inc)
  • Nephron Pharmaceuticals Corp
  • NeuroRx
  • Nipro Pharma Corp
  • Northern RNA Inc
  • Novartis AG
  • Novartis Farma SpA
  • Novasep Holding SAS
  • Novavax
  • Oakwood Laboratories LLC
  • Oxford BioMedica Plc
  • Panacea Biotec Ltd
  • Par Sterile Products LLC
  • Patheon NV (Thermo Fisher Scientific)
  • PCI Pharma Services
  • Pfizer Inc
  • PharmaMar
  • Pharmaniaga Berhad
  • Pharmasyntez
  • Pharmstandard
  • Polymun Scientific Immunbiologische Forschung GmbH
  • PolyPeptide Group AG
  • Polyvac
  • PT Bio Farma
  • Quotient Sciences Ltd
  • Recipharm AB
  • RedHill Biopharma
  • Regeneron Pharmaceuticals Inc
  • Rentschler Biopharma SE
  • Rhein-Minapharm Biogenetics SAE
  • Richter-Helm BioLogics GmbH & Co KG
  • Ridgeback
  • R-Pharm
  • Saidal
  • Samsung Biologics Co Ltd
  • Sanofi
  • Saptagir Laboratories Pvt Ltd
  • Sciarra Laboratories Inc
  • Serum Institute of India Pvt Ltd
  • SGS Life Science Services
  • Shenzhen Yuanxing Gene Technology Co Ltd
  • Shilpa Medicare Ltd
  • Siegfried Holding AG
  • Sinovac Biotech Ltd
  • SK Bioscience Co Ltd
  • Sorrento Therapeutics Inc
  • Sothema
  • Sovereign Pharma Pvt Ltd
  • Spera Nexus Inc
  • Spera Pharma Inc
  • STC Biologics Inc
  • Stelis Biopharma Pvt Ltd
  • Sterling Pharma Solutions Ltd
  • Strides Pharma Science Ltd
  • Summit Biosciences Inc
  • Supriya Lifescience Ltd
  • Symbiosis Pharmaceutical Services Ltd
  • Synairgen
  • Sypharma Pty Ltd
  • The Biovac Institute
  • The State Research Center of Virology and Biotechnology VECTOR
  • TopRidge Pharma Ltd
  • Turk Ilac ve Serum Sanayi AS
  • Uniao Quimica Farmaceutica Nacional SA
  • Unigen Co Ltd
  • UPM Pharmaceuticals Inc
  • Vabiotech
  • Vacsera
  • Valneva
  • Vaxart
  • Vectura Group Plc
  • Vetter Pharma-Fertigung GmbH & Co KG
  • VGXI Inc
  • Vibalogics GmbH
  • Vigene Biosciences Inc
  • Virchow Biotech Pvt Ltd
  • Wacker Chemie AG
  • Waisman Biomanufacturing
  • WuXi Biologics
  • Zydus Healthcare Ltd